FFA
BNGO icon

Farther Finance Advisors’s Bionano Genomics BNGO Stock Holding History

Farther Finance Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-158
Closed -$270 – 5474
2025
Q3 		$270 Buy
+158
New +$502 ﹤0.01% 4663
2025
Q2 		– Sell
-5
Closed -$16 – 4520
2025
Q1 		$16 Hold
5
– – ﹤0.01% 4200
2024
Q4 		$92 Buy
+5
New +$85 ﹤0.01% 3795
2024
Q3 		– Hold
0
– – – 3954

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

Farther Finance Advisors's BNGO Position: Q4 2025 in Review

Farther Finance Advisors sold out of Bionano Genomics (BNGO) in Q4 2025, closing a stake of 158 shares — an estimated $270 sold.

Farther Finance Advisors first reported a position in BNGO in Q4 2024 and held it in 3 quarters. The position peaked at $270 in Q3 2025. 32 funds tracked by Wall St. Rank hold BNGO as of Q4 2025.

  • Farther Finance Advisors reported no remaining Bionano Genomics position as of Q4 2025 after selling out during the quarter.
  • Farther Finance Advisors sold 158 Bionano Genomics shares in Q4 2025, an estimated $270.
  • Farther Finance Advisors first reported a position in Bionano Genomics in Q4 2024 and held it in 3 quarters.
  • Farther Finance Advisors's Bionano Genomics position peaked at $270 in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2025.

Based on Farther Finance Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.